Literature DB >> 17715409

Long-term mortality after gastric bypass surgery.

Ted D Adams1, Richard E Gress, Sherman C Smith, R Chad Halverson, Steven C Simper, Wayne D Rosamond, Michael J Lamonte, Antoinette M Stroup, Steven C Hunt.   

Abstract

BACKGROUND: Although gastric bypass surgery accounts for 80% of bariatric surgery in the United States, only limited long-term data are available on mortality among patients who have undergone this procedure as compared with severely obese persons from a general population.
METHODS: In this retrospective cohort study, we determined the long-term mortality (from 1984 to 2002) among 9949 patients who had undergone gastric bypass surgery and 9628 severely obese persons who applied for driver's licenses. From these subjects, 7925 surgical patients and 7925 severely obese control subjects were matched for age, sex, and body-mass index. We determined the rates of death from any cause and from specific causes with the use of the National Death Index.
RESULTS: During a mean follow-up of 7.1 years, adjusted long-term mortality from any cause in the surgery group decreased by 40%, as compared with that in the control group (37.6 vs. 57.1 deaths per 10,000 person-years, P<0.001); cause-specific mortality in the surgery group decreased by 56% for coronary artery disease (2.6 vs. 5.9 per 10,000 person-years, P=0.006), by 92% for diabetes (0.4 vs. 3.4 per 10,000 person-years, P=0.005), and by 60% for cancer (5.5 vs. 13.3 per 10,000 person-years, P<0.001). However, rates of death not caused by disease, such as accidents and suicide, were 58% higher in the surgery group than in the control group (11.1 vs. 6.4 per 10,000 person-years, P=0.04).
CONCLUSIONS: Long-term total mortality after gastric bypass surgery was significantly reduced, particularly deaths from diabetes, heart disease, and cancer. However, the rate of death from causes other than disease was higher in the surgery group than in the control group. Copyright 2007 Massachusetts Medical Society.

Entities:  

Mesh:

Year:  2007        PMID: 17715409     DOI: 10.1056/NEJMoa066603

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  724 in total

1.  Glucose Metabolism Parameters and Post-Prandial GLP-1 and GLP-2 Release Largely Vary in Several Distinct Situations: a Controlled Comparison Among Individuals with Crohn's Disease and Individuals with Obesity Before and After Bariatric Surgery.

Authors:  Daniéla Oliveira Magro; Everton Cazzo; Paulo Gustavo Kotze; Ana Carolina Junqueira Vasques; Carlos Augusto Real Martinez; Elinton Adami Chaim; Bruno Geloneze; José Carlos Pareja; Cláudio Saddy Rodrigues Coy
Journal:  Obes Surg       Date:  2018-02       Impact factor: 4.129

Review 2.  Managing medical and surgical disorders after divided Roux-en-Y gastric bypass surgery.

Authors:  Bikram Bal; Timothy R Koch; Frederick C Finelli; Michael G Sarr
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-05-11       Impact factor: 46.802

3.  Predictors of Remission of T2DM and Metabolic Effects after Laparoscopic Roux-en-y Gastric Bypass in Obese Indian Diabetics-a 5-Year Study.

Authors:  Aparna Govil Bhasker; Carlyne Remedios; Payal Batra; Amit Sood; Shehla Shaikh; Muffazal Lakdawala
Journal:  Obes Surg       Date:  2015-07       Impact factor: 4.129

4.  Evolution of type 2 diabetes mellitus in non morbid obese gastrectomized patients with Roux en-Y reconstruction: retrospective study.

Authors:  Enrique Lanzarini; Attila Csendes; Hans Lembach; Juan Molina; Luis Gutiérrez; Johanna Silva
Journal:  World J Surg       Date:  2010-09       Impact factor: 3.352

Review 5.  Reductions in cardiovascular risk after bariatric surgery.

Authors:  Fethi Benraouane; Sheldon E Litwin
Journal:  Curr Opin Cardiol       Date:  2011-11       Impact factor: 2.161

6.  Metabolic laparoscopic gastric bypass for obese patients with type 2 diabetes.

Authors:  Mário Nora; Marta Guimarães; Rui Almeida; Paulo Martins; Gil Gonçalves; Maria José Freire; Tiago Ferreira; Cláudia Freitas; Mariana P Monteiro
Journal:  Obes Surg       Date:  2011-11       Impact factor: 4.129

7.  The effect of gastric bypass on the pharmacokinetics of serotonin reuptake inhibitors.

Authors:  Giselle G Hamad; Joseph C Helsel; James M Perel; Gina M Kozak; Mary C McShea; Carolyn Hughes; Andrea L Confer; Dorothy K Sit; Carol A McCloskey; Katherine L Wisner
Journal:  Am J Psychiatry       Date:  2012-03       Impact factor: 18.112

8.  Impact of Weight Regain on the Evolution of Non-alcoholic Fatty Liver Disease After Roux-en-Y Gastric Bypass: a 3-Year Follow-up.

Authors:  Laísa Simakawa Jimenez; Fábio Henrique Mendonça Chaim; Felipe David Mendonça Chaim; Murillo Pimentel Utrini; Martinho Antonio Gestic; Elinton Adami Chaim; Everton Cazzo
Journal:  Obes Surg       Date:  2018-10       Impact factor: 4.129

9.  Obesity management: what brings success?

Authors:  Ylva Trolle Lagerros; Stephan Rössner
Journal:  Therap Adv Gastroenterol       Date:  2013-01       Impact factor: 4.409

10.  Differential changes in exercise performance after massive weight loss induced by bariatric surgery.

Authors:  Britta Wilms; Barbara Ernst; Martin Thurnheer; Burkhard Weisser; Bernd Schultes
Journal:  Obes Surg       Date:  2013-03       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.